Cargando…
Successful treatment of severe COVID-19 pneumonia with tocilizumab: A series of three cases
Autores principales: | Chochoł-Labun, Joanna, Wachnicka-Truty, Renata, Sinica-Latecka, Małgorzata, Sikorska, Katarzyna, Koziński, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747818/ https://www.ncbi.nlm.nih.gov/pubmed/34708860 http://dx.doi.org/10.5603/CJ.a2021.0138 |
Ejemplares similares
-
Life-threatening COVID-19 and aspergillosis co-infection in a heart transplant recipient: A cardiologist’s nightmare
por: Wachnicka-Truty, Renata, et al.
Publicado: (2022) -
Spectrum of lesions visualized in cardiac magnetic resonance imaging in COVID-19-related myocarditis: Findings from a pilot study of the TRICITY-CMR trial
por: Wojtowicz, Dagmara, et al.
Publicado: (2021) -
ST-segment elevation myocardial infarction as a COVID-19 manifestation in a recent heart transplant recipient
por: Radtke-Łysek, Alicja, et al.
Publicado: (2023) -
IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
por: Galván-Román, José María, et al.
Publicado: (2021) -
Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
por: Kelleni, Mina T.
Publicado: (2021)